The Stanford Byers Center for Biodesign collaborates with other entities within and outside the university to administer translational grant programs that benefit Stanford innovators and researchers. These award programs take full advantage of the funding, resources, and expertise available in Silicon Valley. Over many years, we have developed an exceptional track record in enabling selected projects to “translate” from the university into commercial development.
Our award programs provide seed funding to help promising projects bridge the gap between initial research funding and commercial investments or licenses. Importantly, recipients also receive intensive, hands-on mentorship and practical guidance to more efficiently and effectively advance their technologies toward patient care.
Learn more about these programs and how they help empower our trainees.
Spectrum Medtech Grants
Stanford Biodesign manages health technology grants within the broader National Institute of Health-funded Spectrum program. Projects chosen for these grants must have the objective of translating discoveries into novel health technologies that address important unmet health needs. The program supports projects involving medical devices and mobile technologies used for therapeutic applications and for device-based, patient-specific diagnostic applications. Stanford affiliates from any department are invited to apply for these awards.
Stanford-Coulter Translational Research Grants
Funded by the Wallace H. Coulter Foundation and managed by the Stanford Byers Center for Biodesign in partnership with Stanford Bioengineering, the Coulter program supports multidisciplinary teams of biomedical engineers and clinical scientists performing translational research on unmet healthcare needs. Teams must include both a principle investigator from a clinical department in the Stanford University School of Medicine and from the Bioengineering department, with any resulting intellectual property owned by Stanford University.
UCSF-Stanford Pediatric Device Accelerator
The UCSF-Stanford Pediatric Device Accelerator offers $350,000 in seed funding annually (up to $50,000 per project) combined with customized product development and commercialization advising from experienced innovators and industry leaders to help drive promising pediatric device ideas towards market availability for patient benefit.
Biodesign Summer Extension
Each May, the Stanford Biodesign Innovation Fellows and students from the graduate-level Biodesign Innovation course may apply for grants to pursue their projects through the summer. Recipients use this time to further de-risk their technologies, develop business plans, and line up additional funding to take their projects to the next level.
Students in a subset of other Stanford Biodesign courses may apply for 1 or 2 quarters of project funding through the new Biodesign NEXT extension funding program. The purpose of NEXT is to provide high-performing teams with additional time and resources to help them advance their technologies. It also extends the learning experience to help prepare aspiring innovators for careers in health technology innovation.
Robert Howard Next Step Award
Every year, McKinsey Design (formerly LUNAR), a global leader in product design and development, selects a Stanford team to receive complimentary design and engineering consulting from their Health + Medical team to help advance a health technology project toward patient care. Teams from across Stanford are eligible to apply for this prize, known as the Robert Howard Next Step Award.
Please contact Linda Lucian with questions regarding these funding opportunities.